Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Gross Profit | 2,240 | 1,330 | 1,940 | 1,990 | 1,900 |
| Operating Expenses | 1,120 | 1,170 | 1,460 | 1,620 | 1,600 |
| Operating Income | -1,120 | -1,170 | -1,460 | -1,620 | -1,600 |
| Pre-tax Income | -1,120 | -1,170 | -1,460 | -1,620 | -1,600 |
| Net Income Continuous | -1,120 | -1,170 | -1,460 | -1,620 | -1,600 |
| Net Income | $-1,120 | $-1,170 | $-1,460 | $-1,620 | $-1,600 |
| EBITDA(a) | $-730 | $-770 | $-1,030 | $-1,180 | $-1,170 |